1 / 31

QUERI’s Research/Implementation Pipeline…

Explore the implementation pipeline for hypertension self-management interventions, including patient and provider support, telemedicine initiatives, and cost-effective strategies.

jpalazzolo
Download Presentation

QUERI’s Research/Implementation Pipeline…

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Rushing Through the Implementation Pipeline: Hypertension Self-ManagementHayden B. Bosworth, Ph.D.George L. Jackson, Ph.D., MHABen J. Powers, MD, MHSCenter for Health Services Research in Primary Care Durham VA Medical CenterVA Quality Enhancement Research Initiative (QUERI) 2008 Annual Meeting

  2. QUERI’s Research/ImplementationPipeline… Identify Research Area Implement Intervention & Document outcome Identify Best Practice Clinical Research / Guideline Development Implementation Research Implementation Policy, Improved Health Mainstream Health Services Research Assess Existing Practice Phase 1 Pilot Projects Phase 2 Small-Scale Demonstrations Phase 3 Regional Demonstrations Phase 4 “National Rollout” Slide presented developed by VA Quality Enhancement Research Initiative (QUERI)

  3. Veteran Study To Improve The Control of Hypertension (V-STITCH) Study Design • A randomized controlled trial testing two interventions designed to improve BP control • Patient Intervention: Early Self-Management • Provider Intervention: Decision Support • Brief telephone intervention improved BP control by 21% at 24 months • 12.6% improvement compared to the non-behavioral group • No increase in clinic utilization • Cost effective • Computer Decision Support did not significantly improve BP control rates at 24 months

  4. Take Control of Your Blood pressure (TCYB) Study Design • A 2-year randomized controlled trial • Focus on patient self-management • The nurse administered patient intervention • Home BP Monitoring • Combined telephone intervention and home BP improved BP control by 13% at 24 months • 17% improvement compared to the non-behavioral group • SBP improved 6 mm/hg • DBP improved 4 mm/hg • No increase in clinic utilization • Cost effective - ~$200 per year

  5. Hypertension Intervention Nurse Telemedicine Study (HINTS) Design • A 18 month randomized controlled trial • Focus on patient self-management • The nurse administered patient intervention • Home BP Monitoring • Medication management by MDs • Completed recruitment • 600 patients • 50% recruitment rate • > 90% 12-motnth retention • 50% African American • 45% have diabetes

  6. Telephone Intervention • Behavioral interventions to enhance hypertension control • Intervention implemented in nontraditional setting - outside of the clinic, easily administered via the telephone • Delivered by nurses or other clinicians • Tailoring the intervention to patients’ needs - this ensures a more cost efficient method of implementing the intervention • Multiple hypertension-related behaviors addressed • Software allows the integration of patient, medical records, and provider information • Emphasis on cultural issues related to hypertension

  7. HTN IMPROVE: Quality Improvement Project Hypertension Telemedicine Nurse Implementation Project for Veterans

  8. In the Pipeline – Summary ofHTN-IMPROVE • The study is addressing four specific aims: • 1) Assess the implementation of an evidence-based behavioral intervention to improve BP levels. • 2) Evaluate the clinical impact of the intervention to promote and improve BP levels as it is implemented. • 3) Assess the organizational factors associated with the sustainability of the intervention to improve BP levels. • 4) Assess the cost of the intervention to improve BP levels as it is implemented by VA facilities.

  9. In the Pipeline – Summary of HTN-IMPROVE • Methods: • 12 geographically diverse VA sites within two Veteran Integrated Service Networks (VISNs) • 6 sites implementing the behavioral telephone intervention • 6 control sites. • The unit of analysis is patients with an annual inadequate BP control. • Phase I • Conducting a needs assessment and evaluating barriers and facilitators for implementing the proposed behavioral intervention at each of the 6 intervention sites. • Phase II • Examining the impact of the interventions by comparing 12-month pre/post changes in BP control obtained from medical records for individual patients who receive the intervention compared to a individuals from the 6 control sites. • Phase III • Examine the sustainability of the intervention and examine what organizational factors facilitate or hinder the sustained implementation of the study. • Phase IV. • Examine the implementation costs of disseminating the telephone based behavioral interventions.

  10. Intervention Overview • 6 intervention and 6 control facilities • .5 FTE interventionist (e.g., nurse) • 500 patients per facility (250 enrolled every 6 months) • Use centralized software on Durham server • Call patient every 4 weeks • Calls last approximately 5-10 minutes • Interventionist may do several modules each call

  11. Eligibility and Referral • Criterion 1 – Blood Pressure: Mean of outpatient BP measurements in the last 365 days. Systolic BP > 140 mmHg or Diastolic BP > 90 mmHg • Criterion 2 – Assigned Primary Care Provider at the VA The patient must have an assigned primary care provider at the VA • Criterion 3 – Previous Visits to VA Must have had 3 or more visits in the past 730 days at the facility to a primary care clinic. • Criterion 4 – Hypertension ICD-9 CM Diagnoses

  12. Eligibility & Referral Primary Method: PDP/CPRS Referral Step 1: Nurse-administered self-management support added as option to hypertension reminder Step 2:Templated consult Step 3: Feedback loop from interventionist to physician (initial note indicating participation co-signed by PCP)

  13. Implementation Staffing Implementation & Core Team: • Site champion(s) • Nurse interventionist(s) • Site administrators • Site IT

  14. Timeline • August 2008 – Confirm facility participation • September 2008 – January 2009 • Implementation preparation (surveys, interviews) • Training • Site visit to your facility • Monthly calls to learn from each other • January 2009 – Test system with hypothetical patients • February 2009 – Fully implement intervention as part of study • February 2009-Frebruay 2010 – implement intervention recruitment • Monthly calls to learn from each other • Support from Durham • February 2010-February 2011 – Patient follow-up completed • February 2011-February 2012 – Secondary data follow-up

  15. Implementation Challenges

  16. Clinical Trial Investigators also part of ambulatory care staff Local project coordinator keeps things moving Implementation Need for administrative, PCP, and nursing champions Regular teleconference contact with Durham team Developing Site Champions Key Questions: • How do you identify enthusiastic champions at willing facilities? • Do the site champions have the necessary resources and facility backing?

  17. Clinical Trial Identified and recruited through central data pull. Implementation Pts referred from providers? OR Identified and recruited centrally (i.e. central data pull)? Patient Recruitment Key Questions: • Which recruitment procedure works best with existing clinic workflow? - Which would be most acceptable and sustainable for clinics?

  18. Clinical Trial 1 FTE Research Nurse Implementation 0.5 FTE Clinic nurse 1 person= 0.5FTE OR 5 people =0.5FTE? Identifying the Interventionist Key Questions: • How did the clinics prefer to allocate their nursing resources? - Can we still maintain the fidelity of the intervention with different models?

  19. Clinical Trial Intervention operates independently of usual care. Call schedule negotiated between study nurse and patient Implementation Scheduled nurse telephone appointments OR Nurse adds to workflow when possible Integrating into Workflow Key Questions: • Can we fit this into usual clinic operating hours? - How do we document nurse workload credit for time spent on intervention?

  20. Clinical Trial IRB approval Implementation Addressing multiple interpretations Is it research at Durham, but QI elsewhere? Working with IRB(s) Key Questions: -What constitutes quality improvement? -Collaborating with people not accustomed to working with IRBs.

  21. Clinical Trial Clearly defined control groups Intent to treat analysis starts at randomization Implementation Must define control groups Same-site controls Different-site controls Intent to treat not as clear Evaluating intervention Impact Key Questions: -Who are the most appropriate control patients/sites? -What causes a patient to become part of the analysis?

  22. Summary • Intervention tested in 3 separate trials with > 2500 subjects – takes along time • Moving into the realm of implementation • New challenges • Identifying partners • Integrating into regular work of clinic • Obtaining resources • Measuring success • Expanding beyond hypertension to other CVD

  23. Acknowledgements • VA Health Services Research Investigator Initiated Award, 2001-06 • NHLBI Grant R01 HL070713 (2003-2009) • Pfizer Health Communication Initiative Award (2004-2006) • Established Investigator Award, American Heart Association (2006-2011) Danny Almirall Bryan Weiner Eugene Oddone Mike Newell Teresa Damush Amy Kaufman Pam Gentry Daniel Lee

  24. Contact Information • Hayden Bosworth – hayden.bosworth@duke.edu • George L. Jackson – george.l.jackson@duke.edu • Ben Powers – power017@mc.duke.edu

  25. Relevant Publications 1. Bosworth HB, Olsen MK, McCant F, et al. Hypertension Intervention Nurse Telemedicine Study (HINTS). Am Heart J 2007;153(6):918-24. 2. Bosworth HB, Olsen MK, Goldstein MK, et al. The veterans' study to improve the control of hypertension (V-STITCH): design and methodology. Contemp Clin Trials 2005;26:155-68. 3. Chan AS, Coleman RW, Martins SB, et al. Evaluating provider adherence in a trial of a guideline-based decision support system for hypertension. Medinfo 2004;11(Pt 1):125-9. 4. Goldstein MK, Coleman RW, Tu SW, et al. Translating research into practice: organizational issues in implementing automated decision support for hypertension in three medical centers. J Am Med Inform Assoc 2004;11(5):368-76. 5. Goldstein MK, Hoffman BB, Coleman RW, et al. Implementing clinical practice guidelines while taking account of changing evidence. Proc AMIA Symp 2000:300-4. 6. Goldstein MK, Hoffman BB, Coleman RW, et al. Patient safety in guideline-based decision support for hypertension management: ATHENA DSS. Proc AMIA Symp 2001:214-8. 7. Lin ND, Martins SB, Chan AS, et al. Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care. AMIA Annu Symp Proc 2006:494-8. 8. Bosworth HB, Oddone EZ. Telemedicine and Hypertension. J Clin Outcomes Management 2004;11(8):517-522. 9. Bosworth HB, Oddone EZ, Weinberger M. Patient treatment adherence: Concepts interventions, and measurement. Mahwah, NJ: Lawrence Erlbaum Associates, 2006. 10. Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med 2006;119(1):70. 11. Bosworth HB, Oddone EZ. A model of psychosocial and cultural antecedents of blood pressure control. Journal of the National Medical Association 2002;94:236-248. 12. Bosworth HB, Olsen MK, Gentry P, et al. Nurse administered telephone intervention for blood pressure control. Patient Educ Couns 2005;57(1):5-14. 13. Bosworth HB, Olsen MK, Oddone EZ. Improving blood pressure control by tailored feedback to patients and clinicians. Am Heart J 2005;149(5):795-803.

  26. Single disease vs. multimorbidity self-mgmt? • Two key questions 1.) Is there a “spillover” effect from disease-focused self-mgmt onto other conditions? 2.) Is it possible to address multiple conditions simultaneously in a self-management intervention?

  27. Self-management spillover • VSTITCH • HbA1c among patients with diabetes: • 0.46% reduction in HbA1c over two years compared to usual care (95% CI, 0.04% to 0.89%; p=0.03). • LDL cholesterol: • 0.9mg/dl between group difference (95% CI, -7.3mg/dl to 5.6mg/dl; p=0.79). Powers et al. SGIM annual meeting 2008.

  28. Comprehensive self-management • Cholesterol, Hypertension, and Glucose Education (CHANGE) study • RWJ Disparities Research for Change • Supporting Post-MI Risk Modification Intervention via Telemedicine Evaluation (SPRITE) • AHA Pharmaceutical Roundtable Outcome Research

  29. Eligibility & Referral Secondary Method: Physician referral from general clinic Step 1:Physician refers patient to interventionist Step 2: Feedback loop from interventionist to physician

  30. Eligibility & Referral Tertiary Method: Interventionist referral Step 1: Patient pull list reviewed for eligible participant Step 2: Nurse contacts patients based on eligibility criteria Step 3: Patients with most recent outpatient BP measurements contacted first Step 4: PCP gets note and can opt out of patient contact within 72 hours

  31. Clinical Trial Quantitative results patient level Implementation Qualitative and quantitative results both organization and patient Evaluating Successful Implementation Key Questions: -How do you develop a research team with needed expertise? -What frameworks will be used for doing the evaluation?

More Related